Phase
Condition
Urinary Tract Infections
Treatment
Chlorhexidine
Sterile Water
Clinical Study ID
Ages 55-89 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Post-menopausal female between age 55 and 89
No post-menopausal bleeding
Diagnosis of recurrent urinary tract infection (UTI) in the electronic health recordor as two culture proven UTIs in 6 months or three culture proven UTIs in 12 months
At least one UTI in the 6 months prior to entering the study
Asymptomatic for UTI symptoms at the time of enrollment.
On vaginal estrogen therapy for at least 6 weeks prior to enrollment
Ready access to email and internet
Exclusion
Exclusion Criteria:
Recent prophylactic antibiotic use (washout period of 4 weeks)
Neurogenic bladder
Diagnosis of urinary retention
Uncorrected Stage III-IV prolapse
Indwelling catheter or need for intermittent self-catheterization
History of complicated UTIs
History of interstitial cystitis or bladder pain syndrome
History of fecal incontinence/accidental bowel leakage
Greater than 14 bowel movements per week
Non-English speaking
Allergy to chlorhexidine gluconate
Inability to utilize vaginal estrogen therapy
Recent urogynecological or urologic surgery (<12 weeks)
Study Design
Study Description
Connect with a study center
Oregon Health & Science University
Portland, Oregon 97239
United StatesSite Not Available
Oregon Health & Science University
Portland 5746545, Oregon 5744337 97239
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.